Tirzepatide 15mg is a novel peptide with dual GIP and GLP-1 receptor agonist activity, demonstrating superior efficacy in glucose control and weight management compared to selective GLP-1 agonists. This pharmaceutical grade compound (CAS 2023788-19-2) is supplied as white powder with molecular formula C225H348N48O68 and molecular weight 4813.45.
Research indicates Tirzepatide 15mg has greater affinity for GIP receptors than GLP-1 receptors, producing more significant reductions in hyperglycemia. The compound mimics natural GIP action at GIP receptors while maintaining GLP-1 receptor activity.
Our Tirzepatide 15mg is manufactured under strict quality control with purity exceeding 99% (HPLC verified). The product is suitable for various research applications including metabolic disorder studies and diabetes research.
Proper storage is essential for maintaining peptide integrity. We recommend storing Tirzepatide 15mg in dry, dark conditions at 0-4°C for short term use or -20°C for long term preservation. Avoid repeated freeze-thaw cycles and prolonged exposure to air or light.
For research use only. Not for human consumption. This product is intended solely for laboratory research purposes by qualified professionals.